Literature DB >> 35001680

Linear IGA bullous dermatosis potentially triggered by vaccination.

Alberto Corrà1, Veronica Bonciolini2, Lavinia Quintarelli1, Alice Verdelli3, Marzia Caproni1.   

Abstract

Linear IgA bullous dermatosis (LABD) is a mucocutaneous autoimmune blistering disease affecting both adults and children. It is caused by IgA antibodies targeting multiple antigens along the basement membrane zone, leading to disruption of dermoepidermal junction and development of bullous lesions which often presents in characteristic arrangement. Although most LABD cases have been reported to be idiopathic, different triggers have been described, including several drugs and infection. However, the occurrence of vaccine-induced cases of LABD is not widely known and accepted due to the few reports available. We present two cases of LABD occurred following different triggers, rising the suspicion for a possible pathogenetic role of vaccines.

Entities:  

Keywords:  adverse reaction; autoimmune blistering disease; dermatology; linear IgA bullous dermatosis; papillomavirus; vaccines

Mesh:

Substances:

Year:  2022        PMID: 35001680      PMCID: PMC8753231          DOI: 10.1177/20587384211021218

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


Introduction

Linear Immunoglobulin A bullous dermatosis (LABD) is a rare acquired autoimmune subepithelial bullous disease characterized by linear deposition of IgA along the basement membrane zone (BMZ) targeting several autoantigens. The clinical presentation is heterogeneous and can mimic other blistering diseases such as dermatitis herpetiformis and bullous pemphigoid. However, characteristic cutaneous lesions consist of tense arciform bullae in ‘string-of-pearls’ configuration. LABD can affect both adults and children, with similar histological and immunopathological features. However, LABD generally shows spontaneous resolution in children but not in adults. Incidence also differs between adults and children, even changing among countries. Most cases of childhood LABD are idiopathic, but drugs and infections were reported as potential triggering factors. In adults, malignancies and influenza vaccination also may act as triggers.[4,5] We will present two cases of LABD occurred following different triggers, both rising the suspicion for a possible pathogenetic role of vaccines.

Case reports

Case 1

A 1-year-old male child was admitted for severe blistering eruption. One week before he was administered amoxicillin-clavulanic-acid for upper airway infection, while 2 weeks earlier he received anti-measles, -mumps and -rubella vaccination. On physical examination, tense bullous lesions of about 3–10 mm in diameter, most in ‘string-of-pearls’ configuration, appeared on upper limbs, buttocks and abdomen, associated with erythema and crusts (Figure 1). The child appeared restless and distressed for intense itch. Lesional and perilesional biopsies were taken from the buttocks for histology and direct immunofluorescence (DIF). Histology showed subepidermal blistering with neutrophilic dermal infiltration, while DIF revealed linear IgA and C3 deposition along the BMZ (Figure 1). Indirect immunofluorescence (IIF) on human salt-split-skin substrate was negative. Clinical features and DIF supported the diagnosis of LABD of childhood. Amoxicillin-clavulanic acid was discontinued while topical steroid treatment was started, considering parents rejection for systemic therapies. Complete resolution was obtained within a week, without local side effects. The topical therapy was continued for 4 weeks. One month later, a recurrence of mild-itchy blisters occurred on buttocks and limbs following further intake of amoxicillin for a new upper airway infection. Considering the exacerbation after drug re-administration, the Naranjo Score applied for amoxicillin-clavulanic acid was 5, stating the association as probable. The recurrence was controlled simply suspending the drug intake without adjunctive therapies.
Figure 1.

(a–d) Tense bullous lesions, some of which in the typical ‘string-of-pearls’ configuration, in periorificial regions, upper limbs and abdomen. (e) Linear IgA deposition associated with linear C3 deposition along the BMZ of the perilesional skin.

(a–d) Tense bullous lesions, some of which in the typical ‘string-of-pearls’ configuration, in periorificial regions, upper limbs and abdomen. (e) Linear IgA deposition associated with linear C3 deposition along the BMZ of the perilesional skin.

Case 2

A 14-year-old girl was admitted for a face eruption appeared 1 week before. Vesicles and small blisters on normal to slightly erythematous skin were located on forehead, cheeks, nose, ears, forearms and dorsal surface of hands (Figure 2a and b). Most of the lesions were grouped in ‘string-of-pearls’ forms, clinically compatible with LABD. Some honey-coloured crusts raised the suspicion of bacterial superinfection. The girl was otherwise healthy, with no recent history of medications. Three weeks before, she got -6, -11, -16, -18 human papillomavirus (HPV) vaccine injection (Gardasil). Perilesional skin biopsy was taken in preauricular area: DIF showed linear IgA deposition along the BMZ (Figure 2c), confirming the diagnostic hypothesis.
Figure 2.

(a, b) Vesicles and blistering lesions on cheeks, nose and forehead in ‘string-of-pearls’ distributions, with some yellowish crusts. (c) Linear IgA deposition along BMZ at DIF performed on perilesional skin biopsy.

(a, b) Vesicles and blistering lesions on cheeks, nose and forehead in ‘string-of-pearls’ distributions, with some yellowish crusts. (c) Linear IgA deposition along BMZ at DIF performed on perilesional skin biopsy. The patient started systemic steroid therapy contemporary with topical retamipulin, getting progressive improvements with complete resolution within 3 weeks.

Discussion

LABD is one of the most common bullous disorders in children and occurs usually at the age of approximately 4–5 years old[2,3,6-8] while few cases are reported in new-borns.[9-12] The clinical heterogeneity of the disease can lead to diagnostic difficulties for differential diagnosis with other bullous diseases, such as bullous pemphigoid and dermatitis herpetiformis, even in cases with blisters in ‘string-of-pearls’ arrangements.[13,14] Conversely, LABD can manifest atypical clinical pictures, such as the prurigo-like variant. Mucosal involvement is less frequent[2,16]; however, previous reports of mucosal or mucosal-dominant LABD could represent misdiagnosed cases of mucous membrane pemphigoid (MMP). Although most cases of LABD are idiopathic, infections and drugs may represent the trigger. Several medications were reported as responsible for drug-induction in adults including antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs), antiretrovirals, diuretics, ACE-inhibitors, anti-epileptics, statins, amiodarone and cyclosporine. By contrast, in children drug-induced LABD has been related to antibiotics and NSAIDs only.[18,19] Amoxicillin-clavulanic acid was described as possible trigger in different cases including two paediatric patients of 2 and 9 years old respectively, and one in a 62-year-old woman.[20,21] Clinical presentation of these cases and, more in general, of drug-induced LABD, consists of classic tense bullae often in annular disposition, but toxic-epidermal-necrolysis-like pattern has been reported in up to 20% of cases in a French study.[22,23] The median interval from start of drug intake to the onset of LABD ranges from 7 to 9 days to 3 weeks and in 20% rapid resolution following discontinuation of the offending drug can be observed, even without specific treatments.[9,23] However, the particularity of our case 1 is related to the possible association of LABD with anti-measles, -mumps and -rubella vaccination. Similar reports are not currently available in literature. One case of LABD shortly after receiving influenza vaccination has been described in a 54-year-old woman, while two paediatric cases occurred 2 weeks after varicella and influenza vaccination are reported. While the possible causative role of amoxicillin was suggested by an involuntary re-challenge test and the Naranjo score, it was not possible to clearly demonstrate that the vaccination was not able to induce the disease, considering the compatible timing. In the second case, the association between LABD and vaccination appears clearer, due to the absence of concomitant therapies. Moreover, another case of LABD following quadrivalent HPV vaccination has been reported, with a latency time of 3 weeks, similarly to our case. Regarding the physiopathology, one hypothesis implies vaccinations as non-specific activators of the immune response, leading to exacerbations of pre-existent autoimmunity or the development of de novo autoimmune diseases. Autoimmunity can also be induced by molecular mimicry between vaccine antigens and BMZ proteins.

Conclusions

To date, the role of vaccinations in LABD induction has little evidence, indeed it is shared only by few case reports. However, the growing number of reports should make clinicians aware of this association, which appears more frequent than a simple coincidence. Possible causative agents should be carefully searched in patients with LABD, since their removal alone may be effective. Further warnings and population-based studies would reveal useful in improving the knowledge of this phenomenon, in particular about the incidence. Moreover, the attention should be raised in 2021 considering the global vaccination plan for COVID-19, which will involve billions of subjects in a short period.
  25 in total

1.  Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.

Authors:  Bethsabée Garel; Saskia Ingen-Housz-Oro; Daniele Afriat; Catherine Prost-Squarcioni; Florence Tétart; Benoit Bensaid; Corina Bara Passot; Marie Beylot-Barry; Vincent Descamps; Sophie Duvert-Lehembre; Sabine Grootenboer-Mignot; Géraldine Jeudy; Angèle Soria; Marie Blanche Valnet-Rabier; Annick Barbaud; Frédéric Caux; Bénédicte Lebrun-Vignes
Journal:  Br J Clin Pharmacol       Date:  2019-01-04       Impact factor: 4.335

Review 2.  Linear IgA bullous dermatosis of neonatal onset: case report and review of the literature.

Authors:  Y Kishida; J Kameyama; M Nei; T Hashimoto; K Baba
Journal:  Acta Paediatr       Date:  2004-06       Impact factor: 2.299

Review 3.  Application of the immunological disease continuum to study autoimmune and other inflammatory events after vaccination.

Authors:  Helen C Koenig; Andrea Sutherland; Hector S Izurieta; Dennis McGonagle
Journal:  Vaccine       Date:  2010-10-29       Impact factor: 3.641

4.  Linear IgA disease presenting as prurigo nodularis.

Authors:  D Torchia; M Caproni; E Del Bianco; E Cozzani; S Ketabchi; P Fabbri
Journal:  Br J Dermatol       Date:  2006-08       Impact factor: 9.302

5.  Linear immunoglobulin A bullous dermatosis.

Authors:  Giulio Fortuna; M Peter Marinkovich
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

6.  Linear IgA Bullous Dermatosis: A Series of 17 Cases.

Authors:  M S Díaz; L Morita; B Ferrari; S Sartori; M F Greco; L Sobrevias Bonells; M A González-Enseñat; M A Vicente Villa; M Larralde
Journal:  Actas Dermosifiliogr (Engl Ed)       Date:  2019-04-20

7.  Childhood linear IgA bullous disease triggered by amoxicillin-clavulanic acid.

Authors:  Jean Chin Ching Ho; Pei Lin Patricia Ng; Suat Hoon Tan; Yoke Chin Giam
Journal:  Pediatr Dermatol       Date:  2007 Sep-Oct       Impact factor: 1.588

8.  [Iga linear bullous dermatosis in children. A series of 12 Tunisian patients].

Authors:  M Denguezli; B Ben Nejma; R Nouira; S Korbi; R Bardi; K Ayed; A S Essoussi; B Jomaa
Journal:  Ann Dermatol Venereol       Date:  1994       Impact factor: 0.777

9.  Autoantibody Profile of a Cohort of 54 Italian Patients with Linear IgA Bullous Dermatosis: LAD-1 Denoted as a Major Auto-antigen of the Lamina Lucida Subtype.

Authors:  Emanuele Cozzani; Giovanni Di Zenzo; Giulia Gasparini; Adele Salemme; Arianna Fay Agnoletti; Camilla Vassallo; Marzia Caproni; Emiliano Antiga; Angelo V Marzano; Riccardo Cavalli; Corrado Ocella; Clara de Simone; Aurora Parodi
Journal:  Acta Derm Venereol       Date:  2020-02-29       Impact factor: 3.875

10.  Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients.

Authors:  Giovanni Genovese; Luigia Venegoni; Daniele Fanoni; Simona Muratori; Emilio Berti; Angelo Valerio Marzano
Journal:  Orphanet J Rare Dis       Date:  2019-05-24       Impact factor: 4.123

View more
  2 in total

Review 1.  Linear Immunoglobulin a Bullous Dermatosis in Children.

Authors:  Francesca Mori; Francesca Saretta; Lucia Liotti; Mattia Giovannini; Riccardo Castagnoli; Stefania Arasi; Simona Barni; Carla Mastrorilli; Luca Pecoraro; Lucia Caminiti; Gian Luigi Marseglia; Annick Barbaud; Elio Novembre
Journal:  Front Pediatr       Date:  2022-07-08       Impact factor: 3.569

2.  Eosinophil-rich linear IgA bullous dermatosis induced by mRNA COVID-19 booster vaccine.

Authors:  William J Nahm; Michelle Juarez; Julie Wu; Randie H Kim
Journal:  J Cutan Pathol       Date:  2022-08-03       Impact factor: 1.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.